Skip to main
BLLN

Billiontoone Inc (BLLN) Stock Forecast & Price Target

Billiontoone Inc (BLLN) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

BillionToOne is a promising molecular diagnostics company with a strong focus on ultrasensitive tests for prenatal genetic testing and cancer therapy selection and monitoring. With over 600 employees, the company has seen impressive growth and success in their current products and has plans for further expansion. Despite competition in the market, BLLN's strong financials and focus on new products make them a top-performing specialty lab and a promising investment opportunity.

Bears say

BillionToOne is facing challenges in maintaining profitability as they are investing heavily in expanding their product portfolio and hiring new employees. In addition, they face stiff competition in the NIPT market from established companies like Natera. While the company has strong reimbursement coverage and potential for growth, their current financial situation may hinder their ability to generate significant profits in the near future. As a financial analyst, a negative outlook is warranted due to the company's current financial and competitive landscape.

Billiontoone Inc (BLLN) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Billiontoone Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Billiontoone Inc (BLLN) Forecast

Analysts have given Billiontoone Inc (BLLN) a Buy based on their latest research and market trends.

According to 8 analysts, Billiontoone Inc (BLLN) has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $125.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $125.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Billiontoone Inc (BLLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.